title: [Active surveillance for low-risk prostate cancer].
abstract: Autopsy studies have confirmed the high prevalence of latent prostate cancer; however, only a certain portion of patients require definite treatment. Active surveillance is one of the treatment options which, according to national and international guidelines, should be offered to patients with newly diagnosed low-risk prostate cancer. Prostate cancer-specific survival is high in these patients; therefore, curative treatment, such as radical prostatectomy, external beam radiotherapy and brachytherapy may be initially deferred in order to avoid therapy-related side effects. In order to qualify for active surveillance, strict inclusion criteria have to be met; nevertheless, the reliable identification of low-risk prostate cancer patients is not always possible. Patients under active surveillance are followed up regularly with prostate-specific antigen (PSA) testing, digital rectal examination (DRE) and repeat prostate biopsies. Due to the heterogeneity of primary prostate tumors precise molecular diagnostic techniques could allow individualized treatment strategies in the future.
authors.affiliation: Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistraße 15, 81377, München, Deutschland. Annika.Herlemann@med.uni-muenchen.de.
authors.forename: Annika
authors.initials: A
authors.lastname: Herlemann
authors.affiliation: Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistraße 15, 81377, München, Deutschland.
authors.forename: Christian G
authors.initials: CG
authors.lastname: Stief
mesh_terms: D000066491:Clinical Decision-Making / Q000379:methods*; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D012307:Risk Factors; D057832:Watchful Waiting / Q000379:methods*
keywords: Active surveillance; Gleason score; Magnetic resonance imaging; Prostate cancer; Prostate-specific antigen
references.citation: Eur Urol. 2013 Feb;63(2):347-53
references.pmid: 22502944
references.citation: PLoS One. 2015 Feb 06;10(2):e0115537
references.pmid: 25658878
references.citation: J Clin Oncol. 2011 Jan 10;29(2):235-41
references.pmid: 21135285
references.citation: N Engl J Med. 2002 Sep 12;347(11):790-6
references.pmid: 12226149
references.citation: BMC Urol. 2013 Apr 11;13:19
references.pmid: 23578089
references.citation: J Urol. 1995 Jul;154(1):131-8
references.pmid: 7539857
references.citation: World J Urol. 2015 Jul;33(7):923-8
references.pmid: 25432525
references.citation: World J Urol. 2015 Jul;33(7):973-9
references.pmid: 25682109
references.citation: Prostate. 2015 Jul 1;75(10):1085-91
references.pmid: 25809289
references.citation: Nat Med. 2009 May;15(5):559-65
references.pmid: 19363497
references.citation: JAMA. 1994 Feb 2;271(5):368-74
references.pmid: 7506797
references.citation: Can J Urol. 2007 Feb;14(1):3429-34
references.pmid: 17324322
references.citation: Genes Chromosomes Cancer. 2012 Jun;51(6):579-89
references.pmid: 22334418
references.citation: Urol Oncol. 2015 Feb;33(2):71.e1-9
references.pmid: 25131660
references.citation: Curr Opin Urol. 2013 May;23(3):273-7
references.pmid: 23422588
references.citation: Eur Urol. 2015 Apr;67(4):637-45
references.pmid: 25454617
references.citation: J Urol. 2007 Sep;178(3 Pt 1):860-3; discussion 863
references.pmid: 17631347
references.citation: BJU Int. 2007 Mar;99(3):554-8
references.pmid: 17407514
references.citation: Urologe A. 2014 Jul;53(7):1031-9
references.pmid: 24957523
references.citation: J Urol. 2006 Apr;175(4):1298-302; discussion 1302-3
references.pmid: 16515984
references.citation: Int J Cancer. 2015 Dec 15;137(12 ):2795-802
references.pmid: 25557753
references.citation: Eur Urol. 2015 Dec;68(6):1045-53
references.pmid: 25656808
references.citation: F1000 Med Rep. 2012;4:16
references.pmid: 22891078
references.citation: Cancer. 1998 Jan 15;82(2):342-8
references.pmid: 9445192
references.citation: J Clin Oncol. 2015 Jan 20;33(3):272-7
references.pmid: 25512465
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Lancet Oncol. 2012 Nov;13(11):e509-17
references.pmid: 23117005
references.citation: J Urol. 2011 Jun;185(6):2143-7
references.pmid: 21496847
references.citation: J Urol. 2011 Dec;186(6):2505; author reply 2506
references.pmid: 22033446
references.citation: J Clin Invest. 2013 Nov;123(11):4918-22
references.pmid: 24135135
references.citation: Cancer. 1993 Feb 1;71(3 Suppl):933-8
references.pmid: 7679045
references.citation: Cancer. 2008 Aug 15;113(4):701-9
references.pmid: 18553365
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Prostate Cancer Prostatic Dis. 2015 Jun;18(2):137-43
references.pmid: 25667108
references.citation: BJU Int. 2012 Jun;109(11):1614-9
references.pmid: 22044485
references.citation: Cancer. 2005 Aug 1;104(3):467-78
references.pmid: 15959911
references.citation: Eur Urol. 2016 Aug;70(2):211-3
references.pmid: 26553331
references.citation: J Natl Cancer Inst. 2006 Mar 1;98(5):355-7
references.pmid: 16507832
references.citation: J Clin Oncol. 2010 Jun 10;28(17):2810-6
references.pmid: 20439642
references.citation: Nat Genet. 2015 Apr;47(4):367-372
references.pmid: 25730763
references.citation: Rofo. 2014 Aug;186(8):795-802
references.pmid: 24557601
references.citation: Eur Urol. 2016 Aug;70(2):233-45
references.pmid: 26215604
references.citation: BJU Int. 2010 Aug;106(3):304-15
references.pmid: 20653654
references.citation: BJU Int. 2013 Mar;111(3):396-403
references.pmid: 22703025
references.citation: Eur J Radiol. 2012 Mar;81(3):456-60
references.pmid: 21354732
references.citation: Br J Cancer. 2013 Jul 9;109(1):272-9
references.pmid: 23722470
references.citation: J Urol. 2011 May;185(5):1656-60
references.pmid: 21419438
references.citation: J Urol. 2014 May;191(5):1286-9
references.pmid: 24745484
references.citation: J Urol. 2011 Sep;186(3):790-7
references.pmid: 21788055
references.citation: BJU Int. 2011 Dec;108(11):1787-93
references.pmid: 21507187
references.citation: J Urol. 2010 Oct;184(4):1322-7
references.pmid: 20723940
references.citation: BJU Int. 2006 Mar;97(3):451-5
references.pmid: 16469006
references.citation: Eur Urol. 2013 Jul;64(1):37-9
references.pmid: 23433806
references.citation: World J Urol. 2015 Jul;33(7):917-22
references.pmid: 26047652
references.citation: J Urol. 2011 Jan;185(1):121-5
references.pmid: 21074212
references.citation: BJU Int. 2004 Aug;94(3):295-8
references.pmid: 15291854
references.citation: Cancer. 2004 Jun 1;100(11):2362-6
references.pmid: 15160339
references.citation: Eur Urol. 2012 Aug;62(2):195-200
references.pmid: 22342775
references.citation: J Urol. 2007 Nov;178(5):1925-8
references.pmid: 17868725
references.citation: BJU Int. 2007 Sep;100(3):540-3
references.pmid: 17550414
references.citation: Eur Urol. 2011 Sep;60(3):597-8
references.pmid: 21806913
references.citation: Urology. 2012 Sep;80(3):564-9
references.pmid: 22770614
references.citation: Cancer. 2010 Mar 1;116(5):1281-90
references.pmid: 20066716
references.citation: Eur Urol. 2014 Jan;65(1):124-37
references.pmid: 24207135
references.citation: J Urol. 2015 Aug;194(2):343-9
references.pmid: 25681290
references.citation: BJU Int. 2016 Jul;118(1):68-76
references.pmid: 26059275
references.citation: J Clin Oncol. 2015 Oct 20;33(30):3379-85
references.pmid: 26324359
references.citation: Dtsch Med Wochenschr. 2015 Sep;140(19):1435-7
references.pmid: 26402179
references.citation: J Urol. 1998 Dec;160(6 Pt 2):2407-11
references.pmid: 9817393
references.citation: BJU Int. 2014 Dec;114(6b):E18-E24
references.pmid: 24712895
references.citation: Cancer. 2008 Apr 15;112(8):1650-9
references.pmid: 18306379
references.citation: N Engl J Med. 2011 May 5;364(18):1708-17
references.pmid: 21542742
references.citation: Urologe A. 2008 Mar;47(3):261-9
references.pmid: 18273597
references.citation: J Clin Oncol. 2009 Oct 20;27(30):4980-5
references.pmid: 19720918
references.citation: J Urol. 2000 Aug;164(2):411-5
references.pmid: 10893598